Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
422
-
Total 13F shares, excl. options
-
57.7M
-
Shares change
-
+190K
-
Total reported value, excl. options
-
$7.35B
-
Value change
-
+$21.4M
-
Put/Call ratio
-
2.13
-
Number of buys
-
174
-
Number of sells
-
-221
-
Price
-
$127.40
Significant Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q4 2021
502 filings reported holding JAZZ - Jazz Pharmaceuticals plc - SHS USD as of Q4 2021.
Jazz Pharmaceuticals plc - SHS USD (JAZZ) has 422 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57.7M shares
.
Largest 10 shareholders include BlackRock Inc. (6.45M shares), VANGUARD GROUP INC (5.54M shares), JPMORGAN CHASE & CO (3.22M shares), WELLINGTON MANAGEMENT GROUP LLP (2.44M shares), STATE STREET CORP (2.33M shares), LSV ASSET MANAGEMENT (1.84M shares), RENAISSANCE TECHNOLOGIES LLC (1.7M shares), FMR LLC (1.64M shares), Polaris Capital Management, LLC (1.51M shares), and GOLDMAN SACHS GROUP INC (1.31M shares).
This table shows the top 422 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.